A phase I study of ispinesib, a kinesin spindle protein inhibitor, administered weekly for three consecutive weeks of a 28-day cycle in patients with solid tumors
(Q82485618)
scientific article published on 13 January 2010
scientific article published on 13 January 2010
Language:
Current Data About
A phase I study of ispinesib, a kinesin spindle protein inhibitor, administered weekly for three consecutive weeks of a 28-day cycle in patients with solid tumors
other details
| description | scientific article published on 13 January 2010 |
External Links
| (P356) |
10.1007/S10637-009-9374-X
|
| (P698) |
20069338
|
| (P6179) |
1030573628
|